BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 38676947)

  • 1. A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo.
    Peng BL; Ran T; Chen X; Ding JC; Wang ZR; Li WJ; Liu W
    J Med Chem; 2024 May; 67(10):7921-7934. PubMed ID: 38713486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CARM1-mediated histone H3 arginine methylation in protecting histone acetylation by releasing corepressors from chromatin.
    Wu J; Cui N; Wang R; Li J; Wong J
    PLoS One; 2012; 7(6):e34692. PubMed ID: 22723830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation and methylation in nuclear receptor gene activation.
    Xu W; Cho H; Evans RM
    Methods Enzymol; 2003; 364():205-23. PubMed ID: 14631847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage.
    Spruijt CG; Luijsterburg MS; Menafra R; Lindeboom RG; Jansen PW; Edupuganti RR; Baltissen MP; Wiegant WW; Voelker-Albert MC; Matarese F; Mensinga A; Poser I; Vos HR; Stunnenberg HG; van Attikum H; Vermeulen M
    Cell Rep; 2016 Oct; 17(3):783-798. PubMed ID: 27732854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
    Chen X; Huang MF; Fan DM; He YH; Zhang WJ; Ding JC; Peng BL; Pan X; Liu Y; Du J; Li Y; Liu ZY; Xie BL; Kuang ZJ; Yi J; Liu W
    Nucleic Acids Res; 2024 Apr; ():. PubMed ID: 38676947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of CARM1 in cancer.
    Xie Z; Tian Y; Guo X; Xie N
    Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38619752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.
    Jin W; Zhang J; Chen X; Yin S; Yu H; Gao F; Yao D
    Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188916. PubMed ID: 37196782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer.
    Ramírez J; Hagman J
    Epigenetics; 2009 Nov; 4(8):532-6. PubMed ID: 19923891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function insights into the NuRD chromatin remodeling complex.
    Torchy MP; Hamiche A; Klaholz BP
    Cell Mol Life Sci; 2015 Jul; 72(13):2491-507. PubMed ID: 25796366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Methyl-CpG-Binding Domain 2 and 3 Proteins and Formation of the Nucleosome Remodeling and Deacetylase Complex.
    Leighton G; Williams DC
    J Mol Biol; 2020 Mar; 432(6):1624-1639. PubMed ID: 31626804
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.